Showing results (1371-1380 of 1,387) with videos related to
Sort By:
Pageof 139
Science Translational Medicine|April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsMarco A S Baptista, Kalpana Merchant, Ted Barrett, et al.Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|March 17, 2020
Reference values for the locomotive syndrome risk test quantifying mobility of 8681 adults aged 20-89 years: A cross-sectional nationwide study in JapanKeiko Yamada, Yoichi M Ito, Masao Akagi, et al.Journal of Personality|October 22, 2024
Personal Relative Deprivation and Locus of ControlMitchell J Callan, Robbie M Sutton, Phatthanakit Chobthamkit, et al.Journal of Epidemiology|February 25, 2024
Progress Report of the Tohoku Medical Megabank Community-based Cohort Study: Study Profile of the Repeated Center-based Survey During Second Period in Miyagi PrefectureAtsushi Hozawa, Kumi Nakaya, Naoki Nakaya, et al.Nature|December 24, 1997
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferiC M Fraser, S Casjens, W M Huang, et al.Journal of Neuro-Oncology|August 31, 2022
Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factorsKyung Taek Hong, Jung Woo Han, Hiroshi Fuji, et al.Neuro-Oncology|December 22, 2021
Outcomes of intracranial germinoma-A retrospective multinational Asian study on effect of clinical presentation and differential treatment strategiesKyung-Nam Koh, Ru Xin Wong, Dong-Eun Lee, et al.Journal of Chemical Information and Modeling|August 29, 2023
MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary InformationWouter Heyndrickx, Lewis Mervin, Tobias Morawietz, et al.Journal of Medicinal Chemistry|September 19, 2012
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Xingrong Liu, Charles Baker-Glenn, et al.Science Translational Medicine|May 13, 2021
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's diseaseGai Ayalon, Seung-Hye Lee, Oskar Adolfsson, et al.Pageof 139